Links between enhanced fatty acid flux, protein kinase C and NFκB activation, and apoB-lipoprotein production in the fructose-fed hamster model of insulin resistance

Biochemical and Biophysical Research Communications

Volumn 370, Issue 1, 2008, Pages 134-139

  Ragheb, Rafik ^a,b,c,d,e   Medhat, Amina M ^a   Shanab, Gamila M L ^a   Seoudi, Dina M ^a   Fantus, I G ^b,c,e  

^a Ain Shams University   (Egypt)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

ApoB100 synthesis; Fatty acid; NF B activation; Protein kinase C

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN B100; BISINDOLYLMALEIMIDE; FATTY ACID; FRUCTOSE; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; ISOPROTEIN; LIPOPROTEIN; OLEIC ACID; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; ENZYME ACTIVATION; EX VIVO STUDY; FATTY ACID TRANSPORT; HAMSTER; IN VIVO STUDY; INSULIN RESISTANCE; LIVER FATTY DEGENERATION; LIVER METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ANIMALS; APOLIPOPROTEIN B-100; CRICETINAE; DISEASE MODELS, ANIMAL; FATTY ACIDS, NONESTERIFIED; FRUCTOSE; HEPATOCYTES; HYPERLIPOPROTEINEMIAS; INDOLES; INSULIN RESISTANCE; LIVER; MALE; MALEIMIDES; MESOCRICETUS; NF-KAPPA B; OLEIC ACID; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS;

CRICETINAE;

EID: 41849130943     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.03.044     Document Type: Article

References (31)

1. Paolisso G., Tataranni P.A., Foley J.E., Bogardus C., Howard B.V., and Ravussin E. A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM. Diabetologia 38 (1995) 213-1217
2. Boden G., Chen X., Ruiz J., White J.V., and Rossetti L. Mechanisms of fatty acid-induced inhibition of glucose uptake. J. Clin. Invest. 93 (1994) 438-2446
3. Hawkins M., Barzilai N., Liu R., Hu M., Chen W., and Rossetti L. Role of the glucosamine pathway in fat-induced insulin resistance. J. Clin. Invest. 99 (1997) 2173-2182
4. Oakes N.D., Cooney G.J., Camilleri S., Chisholm D.J., and Kraegen E.W. Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding. Diabetes 46 (1997) 1768-1774
5. Park J.Y., Kim C.H., Hong S.K., Suh K.I., and Lee K.U. Effects of FFA on insulin-stimulated glucose fluxes and muscle glycogen synthase activity in rats. Am. J. Physiol. 275 (1998) E338-E344
6. Roden M., Price T.B., Perseghin G., Petersen K.F., Rothman D.L., Cline G.W., and Shulman G.I. Mechanism of free fatty acid-induced insulin resistance in humans. J. Clin. Invest. 97 (1996) 2859-2865
7. Schmitz-Peiffer C., Browne C.L., Oakes N.D., Watkinson A., Chisholm D.J., Kraegen E.W., and Biden T.J. Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high-fat-fed rat. Diabetes 46 (1997) 169-178
8. Oakes N.D., Cooney G.J., Camilleri S., Chisholm D.J., and Kraegen E.W. Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding. Diabetes 46 (1997) 1768-1774
9. Williamson J.R., Kreisberg R.A., and Felts P.W. Mechanism for the stimulation of gluconeogenesis by fatty acids in perfused rat liver. Proc. Natl. Acad. Sci. USA 56 (1966) 247-254
10. Bevilacqua S., Bonadonna R., Buzzigoli G., Boni C., Ciociaro D., Maccari F., Giorico M.A., and Ferrannini E. Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects. Metabolism 36 (1987) 502-506
11. Rebrin K., Steil G.M., Mittelman S.D., and Bergman R.N. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. J. Clin. Invest. 98 (1996) 741-749
12. Saloranta C., Koivisto V., Widen E., Falholt K., DeFronzo R.A., Harkonen M., and Groop L. Contribution of muscle and liver to glucose-fatty acid cycle in humans. Am. J. Physiol. 264 (1993) E599-E605
13. Sindelar D.K., Chu C.A., Rohlie M., Neal D.W., Swift L.L., and Cherrington A.D. The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog. Diabetes 46 (1997) 187-196
14. Wiesenthal S.R., Sandhu H., McCall R.H., Tchipashvili V., Yoshii H., Polonsky K., Shi Z.Q., Lewis G.F., Mari A., and Giacca A. Free fatty acids impair hepatic insulin extraction in vivo. Diabetes 48 (1999) 766-774
15. Randle P.J., Garland P.B., Hales C.N., and Newsholme E.A. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1 (1963) 785-789
16. Diaz-Guerra M.J., Junco M., and Bosca L. Oleic acid promotes changes in the subcellular distribution of protein kinase C in isolated hepatocytes. J. Biol. Chem. 266 (1991) 3568-23576
17. Carpentier A., Mittelman S.D., Lamarche B., Bergman R.N., Giacca A., and Lewis G.F. Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation. Am. J. Physiol. 276 (1999) E1055-E1066
18. Chen S., Lam T.K., Park E., Burdett E., Wang P.Y., Wiesenthal S.R., Lam L., Tchipashvili V., Fantus I.G., and Giacca A. Oleate-induced decrease in hepatocyte insulin binding is mediated by PKC-delta. Biochem. Biophys. Res. Commun. 346 (2006) 931-937
19. Hennes M.M., Dua A., and Kissebah A.H. Effects of free fatty acids and glucose on splanchnic insulin dynamics. Diabetes 46 (1997) 57-62
20. Boden G., She P., Mozzoli M., Cheung P., Gumireddy K., Reddy P., Xiang X., Luo Z., and Ruderman N. Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-κB pathway in rat liver. Diabetes 54 (2005) 3458-3465
21. Taghibiglou C., Rudy D., Van Iderstine S.C., Aiton A., Cavallo D., Cheung R., and Adeli K. Intracellular mechanisms regulating apoB-containing lipoprotein assembly and secretion in primary hamster hepatocytes. J. Lipid Res. 41 (2000) 499-513
22. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
23. Zhang H., Shi X., Hampong M., Blanis L., and Pelech S. Stress-induced inhibition of ERK1 and ERK2 by direct interaction with p38 MAP kinase. J. Biol. Chem. 276 (2001) 6905-6908
24. Macri J., and Adeli K. Studies on intracellular translocation of apolipoprotein B in a permeabilized HepG2 system. J. Biol. Chem. 272 (1997) 7328-7337
25. Adeli K., Taghibiglou C., Van Iderstine S.C., and Lewis G.F. Mechanisms of hepatic very low-density lipoprotein overproduction in insulin resistance. Trends Cardiovasc. Med. 11 (2001) 170-176
26. Lam T.K., Yoshii H., Haber C.A., Bogdanovic E., Lam L., Fantus I.G., and Giacca A. Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-delta. Am. J. Physiol. Endocrinol. Metab. 283 (2002) E682-E691
27. Lam T.K., Carpentier A., Lewis G.F., Van de G., Werve I.G., Fantus, and Giacca A. Mechanisms of the free fatty acid-induced increase in hepatic glucose production. Am. J. Physiol. Endocrinol. Metab. 284 (2003) E863-E873
28. Taghibiglou C., Carpentier A., Van Iderstine S.C., Chen B., Rudy D., Aiton A., Lewis G.F., and Adeli K. Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular apoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model. J. Biol. Chem. 275 (2000) 8416-8425
29. Parker P.J., Bosca L., Dekker L., Goode N.T., Hajibagheri N., and Hansra G. Protein kinase C (PKC)-induced PKC degradation: a model for down-regulation. Biochem. Soc. Trans. 23 1 (1995) 153-155
30. Taghibiglou C., Rashid-Kolvear F., Van Iderstine S.C., Le-Tien H., Fantus I.G., Lewis G.F., and Adeli K. Hepatic very low density lipoprotein-apoB overproduction is associated with attenuated hepatic insulin signaling and overexpression of protein-tyrosine phosphatase 1B in a fructose-fed hamster model of insulin resistance. J. Biol. Chem. 277 (2002) 793-803
31. Field F.J., Chen H., Born E., Dixon B., and Mathur S. Release of ceramide after membrane sphingomyelin hydrolysis decreases the basolateral secretion of triacylglycerol and apolipoprotein B in cultured human intestinal cells. J. Clin. Invest. 92 (1993) 2609-2619